Elsevier Tweaks Custom Pub Rules

Publishing company Elsevier is revising its policies and procedures for partnering with pharmaceutical companies to create custom publications in response to recent media attention over a fake journal, called the Australasian Journal of Bone and Joint Medicine, created by the company and paid for by Merck.
The Scientist